A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia

Vives, S; Martinez-Cuadron, D; Burgues, JB; Algarra, L; Tormo, M; Martinez-Sanchez, MP; Serrano, J; Herrera, P; Ramos, F; Salamero, O; Lavilla, E; Lopez-Lorenzo, JL; Gil, C; Vidriales, B; Falantes, JF; Serrano, A; Labrador, J; Sayas, MJ; Foncillas, MA; Barciela, MLA; Olave, MT; Colorado, M; Gascon, A; Fernandez, MA; Simiele, A; Perez-Encinas, MM; Rodriguez-Veiga, R; Garcia, O; Martinez-Lopez, J; Barragan, E; Paiva, B; Sanz, MA; Montesinos, P

Montesinos, P (corresponding author), Hosp Univ & Politecn La Fe, Ave Fernando Abril Martorell 106, Valencia 46026, Spain.

CANCER, ; ():

Abstract

BACKGROUND Options to treat elderly patients (>= 65 years old) newly diagnosed with acute myeloid leukemia (AML) include intensive and attenuated c......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索